XML 47 R8.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Operating Activities:      
Net income (loss) $ 9,890 $ (7,152) $ (9,486)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 12,032 12,903 12,755
Stock-based compensation 3,839 3,152 2,724
Bad debt expense (recovery) 233 111 (160)
Deferred income taxes 820 (2,170) 100
Gain on amended supply agreement 0 (507) (2,029)
Gain on cash surrender value of life insurance 0 (240) 0
Cash received from amended supply agreement 0 0 2,333
Changes in operating assets and liabilities:      
Accounts receivable, net (20,193) (37,176) 47,983
Contract assets and liabilities, net 55,333 (14,117) (3,270)
Inventories (7,989) (3,023) 8,213
Income taxes 6,681 996 (6,758)
Prepaid expenses and other current assets (2,626) (237) 453
Accounts payable 9,550 8,152 (2,417)
Accrued liabilities 1,419 8,859 (11,676)
Other, net (230) 1,906 (1,950)
Net cash provided by (used in) operating activities 68,759 (28,543) 36,815
Investing Activities:      
Purchases of short-term investments (5,869) (22,261) (60,018)
Maturities of short-term investments 13,088 35,248 33,189
Purchases of property, plant and equipment, net (4,255) (4,415) (3,624)
Proceeds from life insurance policy 0 1,861 0
Net cash provided by (used in) investing activities 2,964 10,433 (30,453)
Financing Activities:      
Payments on industrial development revenue bonds (400) (400) (400)
Shares withheld in lieu of employee tax withholding (1,454) (712) (398)
Dividends paid (11,998) (11,916) (11,875)
Net cash used in financing activities (13,852) (13,028) (12,673)
Net increase (decrease) in cash, cash equivalents and restricted cash 57,871 (31,138) (6,311)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (957) (347) 1,801
Cash, cash equivalents and restricted cash at beginning of period 61,725 93,210 97,720
Cash, cash equivalents and restricted cash at end of period $ 118,639 $ 61,725 $ 93,210